Which of the product segment will dominate the gene expression analysis market in future?
The
major factors driving the growth of the gene expression analysis market include
decreasing cost of sequencing, rising prevalence of cancer, growing application
areas of genomics, and the availability of gene expression databases.
The
global Gene Expression Analysis Market is expected to reach USD 4.9 billion by
2023 from USD 3.2 billion in 2018, at a CAGR of 8.8%.
Ask for PDF Brochure:...
Top 10 Bioprocess Technology Market – Key Players Are Adopting Different Growth Strategies
Top 10 bioprocess technology market is dominated by GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), and Danaher Corporation (U.S.).
GE Healthcare accounted for the largest share of the global top 10 bioprocess technology market in 2015. The company is engaged in drug discovery, patient monitoring systems, medical...
Cell-based Assays Market worth $22.0 billion by 2025
The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market. However, the growth of the market is likely to be restrained by factors such as the high cost of instruments, restrictions on reagent use, and the lack of infrastructure for cell-based...
In Vitro Toxicology Testing Market – Top Driving Factors and Future Trends 2025
The major factors driving the growth of this in vitro toxicity
testing market are the opposition to animal testing, technological
advancements, and increasing R&D expenditure to detect toxicity at
an early stage during drug development are the primary growth drivers
for this market.According to the new market research report In Vitro Toxicology Testing Market is expected to reach USD 14.9...
Immunoassay Market – Top Driving Factors and Future Trends 2023
The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, and growth in the biotechnology and biopharmaceutical industries are some the major factors driving the growth of this market.
According to the new market research report Immunoassay Market is expected to reach USD 27.15 Billion by 2023...
Bioprocess Containers Market: Booming Emerging Markets
The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 913.3 million in 2017, at a CAGR of 13.2%. The base year considered for the study is 2017, and the forecast for the market is provided for the period between 2018 and 2023.
Growth in the bioprocess containers market is mainly driven by factors such as the increasing demand for biologics,...
Stem Cell Assay Market worth USD 1,978.7 Million by 2023
Factors driving the growth of this market include the rising
incidence of target indications; availability of funding for stem cell
research; technological advancements in stem cell research instruments; and
growth of end-use industries.
The stem
cell assay market was valued at USD 660.9 Million in 2017 and is expected
to reach USD 1,978.7 Million by 2023, at a CAGR of 20.1%.
Selected Market
Dynamics...
Who are the top 10 players operating in the laboratory proficiency testing market?
Proficiency
testing forms an essential precondition for operational excellence and
accreditation in several industries. This is one of the major factors driving
the growth of the proficiency testing market, globally. Also, the stringent
safety and quality regulations for food and pharmaceutical products and the
increasing focus on water testing are the other major factors supporting market
growth.
The...
Cancer Biomarkers Market – Top Driving Factors and Future Trends 2022
The increasing prevalence of cancer, rising government support for research on cancer biomarkers, growing use of biomarkers in drug discovery and development, and increasing use of biomarker tests for diagnostic purposes are the major factors that are driving the growth of this market.
According to research report the global cancer biomarkers market to reach USD 20.4 billion by 2022. and is...
Competent Cells Market – Top Driving Factors and Future Trends 2022
Advancements in molecular cloning research due to the emergence of
new technologies and increasing commercial demand for molecular cloned
products and recombinant proteins are the major factors driving the
growth of the competent cells market.According to research report the global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of...